Cargando…

Disruption of diphthamide synthesis genes and resulting toxin resistance as a robust technology for quantifying and optimizing CRISPR/Cas9-mediated gene editing

We have devised an effective and robust method for the characterization of gene-editing events. The efficacy of editing-mediated mono- and bi-allelic gene inactivation and integration events is quantified based on colony counts. The combination of diphtheria toxin (DT) and puromycin (PM) selection e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Killian, Tobias, Dickopf, Steffen, Haas, Alexander K., Kirstenpfad, Claudia, Mayer, Klaus, Brinkmann, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684134/ https://www.ncbi.nlm.nih.gov/pubmed/29133816 http://dx.doi.org/10.1038/s41598-017-15206-x

Ejemplares similares

Influence of DPH1 and DPH5 Protein Variants on the Synthesis of Diphthamide, the Target of ADP-Ribosylating Toxins
por: Mayer, Klaus, et al.
Publicado: (2017)

Diphthamide affects selenoprotein expression: Diphthamide deficiency reduces selenocysteine incorporation, decreases selenite sensitivity and pre-disposes to oxidative stress
por: Mayer, Klaus, et al.
Publicado: (2018)

Insights into Diphthamide, Key Diphtheria Toxin Effector
por: Abdel-Fattah, Wael, et al.
Publicado: (2013)

Yeast gene KTI13 (alias DPH8) operates in the initiation step of diphthamide synthesis on elongation factor 2
por: Arend, Meike, et al.
Publicado: (2023)

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Diphthamide-deficiency syndrome: a novel human developmental disorder and ribosomopathy
por: Hawer, Harmen, et al.
Publicado: (2020)

Importance of diphthamide modified EF2 for translational accuracy and competitive cell growth in yeast
por: Hawer, Harmen, et al.
Publicado: (2018)

Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Translational fidelity and growth of Arabidopsis require stress-sensitive diphthamide biosynthesis
por: Zhang, Hongliang, et al.
Publicado: (2022)

DPH1 Gene Mutations Identify a Candidate SAM Pocket in Radical Enzyme Dph1•Dph2 for Diphthamide Synthesis on EF2
por: Ütkür, Koray, et al.
Publicado: (2023)

Applications of the CRISPR/Cas system beyond gene editing
por: Anton, Tobias, et al.
Publicado: (2018)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

CRISPR-Cas9 gene editing and human diseases
por: Jinka, Chaitra, et al.
Publicado: (2022)

CRISPR/Cas9 Essential Gene Editing in Drosophila
por: Osadchiy, I. S., et al.
Publicado: (2023)

Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide
por: Wang, Hong-Xia, et al.
Publicado: (2018)

DPH1 and DPH2 variants that confer susceptibility to diphthamide deficiency syndrome in human cells and yeast models
por: Ütkür, Koray, et al.
Publicado: (2023)

Editing of the urease gene by CRISPR-Cas in the diatom Thalassiosira pseudonana
por: Hopes, Amanda, et al.
Publicado: (2016)

Comparison of CRISPR/Cas Endonucleases for in vivo Retinal Gene Editing
por: Li, Fan, et al.
Publicado: (2020)

Harnessing CRISPR-Cas system diversity for gene editing technologies
por: McKay, Alexander, et al.
Publicado: (2021)

Off-target effects in CRISPR/Cas9 gene editing
por: Guo, Congting, et al.
Publicado: (2023)

CRISPR/Cas9-gene editing approaches in plant breeding
por: Saini, Himanshu, et al.
Publicado: (2023)

The enhancement of CRISPR/Cas9 gene editing using metformin
por: Rollins, Jaedyn L., et al.
Publicado: (2023)

Disruption of three polyamine uptake transporter genes in rice by CRISPR/Cas9 gene editing confers tolerance to herbicide paraquat
por: Lyu, Yu-Shu, et al.
Publicado: (2022)

Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9
por: Agudelo, Daniel, et al.
Publicado: (2020)

Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editing
por: Chen, Yangcan, et al.
Publicado: (2022)

CRISPR-Cas9 Gene Editing of the Sal1 Gene Family in Wheat
por: Mohr, Toni, et al.
Publicado: (2022)

Qualitative and Quantitative Detection of CRISPR-Associated Cas Gene in Gene-Edited Foods
por: Ding, Lin, et al.
Publicado: (2023)

Comparison of gene disruption induced by cytosine base editing‐mediated iSTOP with CRISPR/Cas9‐mediated frameshift
por: Dang, Lu, et al.
Publicado: (2020)

CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
por: Liang, Puping, et al.
Publicado: (2015)

Outbred genome sequencing and CRISPR/Cas9 gene editing in butterflies
por: Li, Xueyan, et al.
Publicado: (2015)

Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system
por: Cheong, Taek-Chin, et al.
Publicado: (2016)

Applications of CRISPR/Cas9 for Gene Editing in Hereditary Movement Disorders
por: Im, Wooseok, et al.
Publicado: (2016)

Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research
por: Campbell, Leah J., et al.
Publicado: (2017)

Gene Editing and Crop Improvement Using CRISPR-Cas9 System
por: Arora, Leena, et al.
Publicado: (2017)

Cas9 immunity creates challenges for CRISPR gene editing therapies
por: Crudele, Julie M., et al.
Publicado: (2018)

Edition of TFAM gene by CRISPR/Cas9 technology in bovine model
por: de Oliveira, Vanessa Cristina, et al.
Publicado: (2019)

In Vitro Pre-validation of Gene Editing by CRISPR/Cas9 Ribonucleoprotein
por: Mehravar, Maryam, et al.
Publicado: (2019)

Gene editing using CRISPR-Cas9 for the treatment of lung cancer
por: Castillo, Andres
Publicado: (2016)

CRISPR/Cas9 Gene Editing: An Unexplored Frontier for Forest Pathology
por: Dort, Erika N., et al.
Publicado: (2020)

CRISPR/Cas: a potential gene-editing tool in the nervous system
por: Gao, Yanxia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t6djcj5ferh06mgqkoalmir8ej